Telmisartan vs Olmesartan in Hypertensive Obese Patients

Telmisartan Significantly Improves Insulin Sensitivity in Hypertensive Obese Patients

To evaluate the effect of treatment with Telmisartan Vs Olmesartan in hypertensive obese and overweight patients.

Overweight and obese patients with mild to moderate hypertension (N=65)

Telmisartan 80 mg/day Vs Olmesartan 40 mg/day

3 months

Measurement of insulin, glucose, HOMA and leptin levels

Treatment with Telmisartan for 3 months showed a significant improvement in glycemic parameteres and leptin levels, unlike olmesartan.

Unlike olmesartan telmisartan significantly improves insulin, glucose, HOMA and leptin levels in hypertensive diabetic patients compared to olmesartan.